MRAI
Marpai, Inc.
OTC Markets OTCQXUSDEQUITY
Healthcare
DELAYED
Strong buy
+61/100
Last price
3.35
▼ 0.15 (4.29%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
3.50
Day high
3.35
Day low
3.30
Volume
14.80K
Market cap
$89.88M
P/E (TTM)
—
52W range
0.22 – 4.16
Trailing performance
Returnvs SPY
1W
-0.30%
-2.2%
1M
+10.56%
+9.4%
3M
+425.08%
+420.6%
6M
+1,284.30%
+1,266.1%
YTD
+430.90%
+416.7%
1Y
+118.95%
+102.5%
3Y
+406.81%
+324.6%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on MRAI open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
13.71M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 2, 26 | JOHNSON STEVE ANDREW Chief Financial Officer |
BUY | 1.10K | $682 | Direct |
| May 29, 26 | EITAN YARON I Director |
STOCK | 175.00K | $0 | Direct |
| May 29, 26 | PONS ROBERT M Director |
STOCK | 100.00K | $0 | Direct |
| May 29, 26 | SHIV SAGIV Director |
STOCK | 125.00K | $0 | Direct |
| May 29, 26 | CALABRESE JENNIFER ROSARIO Director |
STOCK | 100.00K | $0 | Direct |
| May 29, 26 | DICLAUDIO COLLEEN Director |
STOCK | 125.00K | $0 | Direct |
| May 29, 26 | LAMENDOLA DAMIEN Chief Executive Officer |
STOCK | 300.00K | $0 | Direct |
| May 29, 26 | JOHNSON STEVE ANDREW Chief Financial Officer |
STOCK | 125.00K | $0 | Direct |
| May 20, 26 | EITAN YARON I Director |
BUY | 10.00K | $2.70K | Direct |
| Feb 19, 26 | SHIV SAGIV Director |
STOCK | 100.00K | $0 | Direct |
| Nov 7, 25 | EITAN YARON I Director |
BUY | 100.00K | $141.50K | Direct |
| Nov 7, 25 | PONS ROBERT M Director |
BUY | 50.00K | $70.75K | Direct |
| Nov 7, 25 | SHIV SAGIV Director |
BUY | 50.00K | $70.75K | Direct |
| Nov 7, 25 | SCRIP DALLAS Chief Operating Officer |
STOCK | 100.00K | $141.50K | Indirect |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
CALABRESE JENNIFER ROSARIO |
Director | 225.00K | Stock Award(Grant) |
DICLAUDIO COLLEEN |
Director | 267.50K | Stock Award(Grant) |
EITAN YARON I |
Director | 1.22M | Stock Award(Grant) |
INTELLIGENT FANATICS CAPITAL MANAGEMENT LLC |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
JOHNSON STEVE ANDREW |
Chief Financial Officer | 1.02M | Purchase |
LAMENDOLA DAMIEN |
Chief Executive Officer | 9.00M | Stock Award(Grant) |
PONS ROBERT M |
Director | 484.20K | Stock Award(Grant) |
POWERS JOHN PAUL |
President | 410.00K | Stock Award(Grant) |
SCRIP DALLAS |
Chief Operating Officer | — | Stock Award(Grant) |
SHIV SAGIV |
Director | 613.67K | Stock Award(Grant) |
Fundamentals
Market cap$89.88M
Enterprise value$119.25M
Revenue (TTM)$16.64M
Gross profit$4.30M
EBITDA$-13.16M
Net income$-16.89M
EPS (TTM)$-7.54
Free cash flow$-492.75K
Total cash$138.00K
Total debt$29.51M
Book value / share$-1.46
Shares outstanding26.83M
Float13.36M
Short % of float0.26%
Dividend yield0.00%
Beta (5Y)4.67
Valuation & profitability ratios
Trailing P/E—
Forward P/E-8.82
PEG ratio—
Price / sales—
Price / book—
EV / revenue7.17
EV / EBITDA-9.06
Gross margin25.87%
Operating margin-82.41%
Profit margin-101.51%
Return on equity—
Return on assets-82.78%
Debt / equity—
Current ratio0.38
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|
| Total revenue | $37.16M | $24.34M | $14.23M | +52.6% |
| Operating revenue | $37.16M | $24.34M | $14.23M | +52.6% |
| Cost of revenue | $24.24M | $17.14M | $10.29M | +41.4% |
| Gross profit | $12.92M | $7.21M | $3.94M | +79.2% |
| Research & development | $1.31M | $3.71M | $1.73M | -64.6% |
| Selling, general & admin | $25.77M | $19.26M | $13.02M | +33.8% |
| Total operating expense | $39.29M | $33.89M | $19.80M | +15.9% |
| Operating income | -$26.37M | -$26.68M | -$15.86M | +1.2% |
| Net interest income | -$1.53M | -$266.78K | -$427.18K | -472.6% |
| Pre-tax income | -$29.04M | -$26.99M | -$16.13M | -7.6% |
| Tax provision | -$290.14K | -$521.13K | -$150.00K | +44.3% |
| Net income | -$28.75M | -$26.47M | -$15.98M | -8.6% |
| Net income to common | -$28.75M | -$26.47M | -$15.98M | -8.6% |
| Basic EPS | -4.14 | -5.24 | -6.36 | +21.0% |
| Diluted EPS | -4.14 | -5.24 | -6.36 | +21.0% |
| EBIT | -$27.51M | -$26.72M | -$15.71M | -3.0% |
| EBITDA | -$22.12M | -$22.59M | -$13.65M | +2.1% |
| Basic shares | 6.95M | 5.06M | 2.52M | +37.4% |
| Diluted shares | 6.95M | 5.06M | 2.52M | +37.4% |
| Line item | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $1.15M | $13.76M | $19.18M | -91.7% |
| Cash & short-term investments | $1.15M | $13.76M | $19.18M | -91.7% |
| Accounts receivable | $1.13M | $1.44M | $208.76K | -21.7% |
| Total current assets | $17.08M | $26.54M | $26.99M | -35.6% |
| Property, plant & equipment | $2.98M | $5.35M | $2.93M | -44.2% |
| Goodwill & intangibles | $10.32M | $16.75M | $14.20M | -38.4% |
| Total assets | $31.68M | $49.95M | $44.20M | -36.6% |
| Total current liabilities | $20.84M | $17.36M | $11.15M | +20.1% |
| Total debt | $4.20M | $6.08M | $2.09M | -31.0% |
| Total liabilities | $45.12M | $43.82M | $14.49M | +3.0% |
| Retained earnings | -$76.75M | -$47.99M | -$21.53M | -59.9% |
| Shareholder equity | -$13.44M | $6.13M | $29.71M | -319.1% |
| Working capital | -$3.76M | $9.18M | $15.85M | -140.9% |
| Net tangible assets | -$23.76M | -$10.61M | $15.51M | -123.8% |
| Shares issued | 7.96M | 5.32M | 5.07M | +49.6% |
| Line item | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|
| Net income | -$28.75M | -$26.47M | -$15.98M | -8.6% |
| Depreciation & amortisation | $5.40M | $4.14M | $2.06M | +30.5% |
| Stock-based compensation | $2.10M | $3.11M | $1.23M | -32.4% |
| Change in working capital | $2.34M | -$16.06M | $1.58M | +114.6% |
| Operating cash flow | -$15.75M | -$35.24M | -$10.80M | +55.3% |
| Capital expenditure | — | -$965.57K | -$1.74M | — |
| Investing cash flow | $1.03M | $32.42M | $9.64M | -96.8% |
| Financing cash flow | $5.10M | $196 | $25.27M | +2,600,186.7% |
| Free cash flow | -$15.75M | -$36.20M | -$12.54M | +56.5% |
| End cash position | $13.49M | $23.12M | $25.93M | -41.6% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Mar 2024 | -0.43 | -0.46 | -7.0% |
| Dec 2023 | -0.19 | -0.09 | +51.9% |
| Sep 2023 | -0.79 | -0.97 | -23.4% |
| Jun 2023 | -0.95 | -1.05 | -10.9% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders51.09%
Held by institutions3.84%
Institutions holding1
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
3.30
+1.44% from price
SMA 20
3.36
-0.22% from price
SMA 50
2.72
+23.26% from price
SMA 100
1.77
+89.53% from price
SMA 200
1.12
+199.78% from price
EMA 12
3.32
+0.99% from price
EMA 26
3.12
+7.38% from price
EMA 50
2.72
+23.36% from price
RSI (14)
56.9
Neutral
MACD (12,26,9)
0.20
Hist -0.03
ATR (14)
0.25
7.48% of price
Realised vol 30D
105.1%
Annualised
Bollinger upper
3.86
20, 2σ
Bollinger lower
2.85
20, 2σ
50 / 200 cross
Golden
2.72 vs 1.12
Trend bias
Above 200
+199.78%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
2.67
More volatile than market
Correlation to SPY
0.20
Largely independent
Realised vol 30D
105.1%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-86.2%
Peak to trough
Max drawdown 5Y
-99.0%
Peak to trough
ATR 14
0.25
7.48% of price
Beta (reported)
4.67
5Y monthly, from filing
Short interest
Shares short
11.51K
Prior 116.62K
Change vs prior
-90.1%
Shorts covering
% of float
0.26%
Normal
% of shares out
0.11%
Against total outstanding
Days to cover
0.1
Liquid
Float
13.36M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 28, 24 | Maxim Group | UPGRADE | Hold | Buy |
| Nov 15, 23 | Maxim Group | DOWNGRADE | Buy | Hold |
| Nov 14, 23 | Maxim Group | DOWNGRADE | Buy | Hold |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio—
Ex-dividend date—
Next pay date—
Last split1:4
Split dateJun 29, 2023
SEC filings
Periodic Financial Reports
10-Q · 2026-08-13
Corporate Changes & Voting Matters
8-K · 2026-07-31
Corporate Changes & Voting Matters
8-K · 2026-07-20
Periodic Financial Reports
10-Q · 2026-05-15
Corporate Changes & Voting Matters
8-K · 2026-05-01
Periodic Financial Reports
10-K · 2026-03-25
Corporate Changes & Voting Matters
8-K · 2026-03-11
Corporate Changes & Voting Matters
8-K · 2026-02-13
Headlines
Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients
Business Wire · 51d ago
Marpai Reports Second Quarter 2026 Financial Results
PR Newswire · 54d ago
Marpai Announces $12 Million Private Placement led by Mitchell Companies
PR Newswire · 70d ago
Marpai Inc. Announces Debt Restructuring Agreements with JGB Capital and AXA, Reducing Debt Service by $26.4 Million Through 2027 and Enhances Near term Liquidity
PR Newswire · 79d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.